Pressroom
-
Telling Doctors Their Patients Fatally Overdosed Reduces Opioid Prescriptions Up to One Year Later
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
Categorized in -
New Dialysis Studies Inform Delivery of Care, Ways to Improve Patient Outcomes
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
Categorized in -
Traditional Vaccination Playbook Doesn’t Work with COVID
New study finds financial incentives and other behavioral nudges made little difference among certain groups.
Categorized in -
No Surprises Act Will Likely Reduce Payments to Most Emergency Medicine Providers, According to New USC Analysis
A payment rule in the No Surprises Act will likely lead to lower rates for emergency medicine procedures.
Categorized in -
Affordable Care Act Exchange Plans Negotiate Lower Hospital Prices Than Commercial Plans, According to New Schaeffer Center Analysis
ACA exchange plans on average paid 89% of what commercial group plans paid for both inpatient and outpatient procedures.
Categorized in -
‘Nudges’ to Reduce Opioid Overuse Also Decrease Inappropriate Benzodiazepine Prescriptions
Informing physicians when a patient dies of an overdose may provide the needed “nudge” to improve prescribing practices.
Categorized in -
Patient Preference for Medical Cannabis Products in the Absence of Clinical Guidelines
New analysis of New York data finds considerable variability in patient product choice, even for patients with the same condition.
Categorized in -
Are California Hospital Systems Rapidly Increasing Prices? The Data Suggest Not All Systems Are Alike
Average price growth was high among California for-profit systems (31% over the study period), while non-profit and public systems had lower average price growth (13%) than nonsystem hospitals (15%).
Categorized in -
Interdisciplinary Panel Offers Solutions to Improve Recruitment for Alzheimer’s Clinical Trials
Experts from the private and public sectors convened a panel to improve recruitment for Alzheimer’s clinical trials.
Categorized in -
Efforts to Save Money on Prescription Drugs Associated with Increased Stroke Risk for Seniors
Tools used by insurers and PBMs to contain costs result in fewer patients using NOACs or warfarin
Categorized in